Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection

Exclusion Criteria

• •o A history of a previous rejection episode in the study eye
• •* A patient exhibiting intraocular inflammation.
• •* A patient with a known sensitivity to any of the ingredients in the study medications
• •* A patient who has a condition (i.e., UNCONTROLLED systemic disease) or is in a situation which in the investigator's opinion may put the patient at significant risk, may confound the study results, or may interfere significantly with the patient's participation in the study
• •* A patient with abnormal eyelid function.
• •* A patient that is exhibiting active corneal ulceration, keratitis, or conjunctivitis, or who has a history of herpetic keratitis.
• •* Presence of any ocular disease that would interfere with the evaluation of the study treatment. However, patients with a history of cystoid macular edema, age-related macular degeneration, controlled glaucoma, corneal neovascularization, and other non-interfering comorbidities may be enrolled.
• •* A patient with a history of non-compliance with using prescribed medication.
• •* Patients who are pregnant or planning to become pregnant within the duration of the study